7.18
機構モデル: 個人および集団分析におけるコンパートメントモデル
機構モデルは、単一ソースデータを使用した個人分析で利用されますが、データ収集誤差によって不完全性が生じ、観測データの完全な予測が妨げられます。数式には、既知の値 (Xi)、観測濃度 (Ci)、測定誤差 (εi)、モデルパラメータ (ϕj)、および i 個の値に対する関連関数 (ƒi) が含まれます。…
個々の分析では、単一ソースデータを含むメカニズムモデルを使用します。ただし、データ収集エラーは、観測データの完全な予測を妨げます。
数式では、Xi、Ci、εi、φj、ƒi は、それぞれ i 値の既知の値、観測された濃度、測定誤差、モデル パラメータ、および関連関数を表します。
最小二乗メトリクスは、予測値と観測値の違いを定量化します。
通常の最小二乗法は、より大きな観測値に偏っています。
加重最小二乗法と最尤法または拡張最小二乗法は、加重係数を組み込むことで OLS を改善します。
母集団分析モデルは、個人間の変動を考慮して、複数の被験者のデータを予測します。
同じ構造モデルが、研究中の特定の薬剤について、すべての個人のデータに適合します。
平均と個々の薬物動態パラメータとの関係は方程式で表され、ηj はランダムな変動性を表します。
さまざまな母集団コンパートメント分析には、ナイーブ平均データ、ナイーブプールデータ、および2段階アプローチが含まれます。
View the full transcript and gain access to JoVE Core videos
Q1: What mathematical components are used in mechanistic models for individual pharmacokinetic analysis?
Mechanistic models use several key mathematical components: Xi represents known values, Ci represents observed concentrations, εi represents measurement errors, ϕj represents model parameters, and ƒi represents the related function. These components work together in equations to predict drug behavior, though data collection errors prevent perfect prediction of observed data.
Q2: How do weighted least squares and maximum likelihood methods improve upon ordinary least squares?
Ordinary least squares (OLS) is biased toward larger observations, limiting prediction accuracy. Weighted least squares (WLS) and maximum likelihood or extended least squares (ML/ELS) methods improve OLS by incorporating a weighting factor that adjusts for observation size differences. This weighting enhances the accuracy of predicted versus observed value comparisons.
Q3: What role does interindividual variability play in population analysis models?
Population analysis models account for interindividual variability—differences between individuals—by using the same structural model to fit all subjects' data for a specific drug. Random variability, represented by ηj in mathematical equations, describes the relationship between mean and individual pharmacokinetic parameters, enabling predictions for multiple subjects simultaneously.
Q4: What are the main types of population compartmental analysis approaches?
Population compartmental analysis includes three main approaches: naïve-average data, naïve pooled data, and the two-stage approach. The two-stage approach further includes standard two-stage (STS) and global two-stage (GTS) methods, which obtain population parameter estimates through iterative processes to improve accuracy.
Q5: How do least-squares metrics function in comparing predicted and observed pharmacokinetic data?
Least-squares metrics quantify differences between predicted and observed values in mechanistic models. These metrics measure how well model predictions match actual concentration observations, helping researchers evaluate model performance. Different least-squares approaches—ordinary, weighted, and maximum likelihood—provide varying levels of accuracy depending on data characteristics.
Q6: Why is the same structural model used for all individuals in population analysis?
Using the same structural model for all individuals in population analysis allows researchers to identify common pharmacokinetic patterns while accounting for interindividual variability through random effects. This approach enables efficient analysis of multiple subjects' data for a specific drug, providing both individual and population-level predictions.
Q7: What limitations do data collection errors impose on mechanistic model predictions?
Data collection errors prevent mechanistic models from achieving perfect prediction of observed data. Measurement errors (εi) introduce uncertainty into observed concentrations, requiring statistical methods like weighted least squares to account for these imperfections and improve model reliability in individual and population pharmacokinetic analyses.